Ketki Vispute

Associate Director, Manufacturing • Autolus Therapeutics

Ketki has 10+ years of experience in the development and manufacturing of CAR-T cells for haematological malignancies. Ketki’s team was the first in Europe to launch the first-ever CAR-T cell clinical trial starting from designing the CAR construct to pre-clinical development followed by scale-up of the process and manufacturing for the clinic. Ketki has delivered 4 phase 1/2 clinical trials in CAR-T therapy and is now working towards commercialising CAR-T manufacturing in the UK. 

Also speaking

Joel Eichmann

Co-Founder & Managing Director • Green Elephant Biotech

Dorothea Ledergerber

Chief Technical Officer • Tigen Pharma

Amandine Breton

Director MSAT & AST, Cell & Gene Therapies • Orchard Therapeutics

Event Info


Pre-Day Events

Discover more about the Pre-Day Events taking place at Advanced Therapies Europe.

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.